http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9961068-A9
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e1a77f78dc0937c8fc2a707a6db32df2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e3830f35387a1c32061dea3ee310851 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eff79e616d550b1ad481630afeeb52bc |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-6445 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-64 |
filingDate | 1999-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_298d4a0522b20fc5f0cc62f340b1e6b1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4785c7fbf7f62588198d8c847f6ebe1 |
publicationDate | 2000-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | WO-9961068-A9 |
titleOfInvention | Anti-prostate cancer vaccines, and methods of making, using and evaluating the same |
abstract | Methods of immunizing individuals against prostate cancer are disclosed. Methods of protecting an individual against prostate cancer and methods of treating individuals who have prostate cancer are also disclosed. Methods of inducing a cellular immune response against prostate specific antigen are also disclosed. In the disclosed methods, a nucleic acid molecule that comprises a nucleotide sequence that encodes prostate specific antigen or an immunologically active fragment thereof is administered to a site on an individual's body. The nucleotide sequence is operably linked to regulatory sequences which control the expression of the nucleotide sequence in cells of the individual. Pharmaceutical compositions are also disclosed. Methods for assessing the effectiveness of a prostate cancer vaccine to induce an immune response against prostate specific antigen in an individual, and kits for performing the same are also disclosed. |
priorityDate | 1998-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 674.